Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 7/2021

01-07-2021 | Chronic Inflammatory Bowel Disease | Original Article

Challenges and Opportunities in Social Media Research in Gastroenterology

Authors: Joy W. Chang, Evan S. Dellon

Published in: Digestive Diseases and Sciences | Issue 7/2021

Login to get access

Abstract

In recent years, social media has transformed how we as gastroenterologists communicate with each other and has grown into an arena of knowledge and peer support for patients. Gastroenterologists commonly use social media for education networking, patient populations use social media for peer support and advocacy, but little is known about how gastroenterologists can use social media to conduct thoughtful and rigorous patient-centered research. Therefore, we aim to introduce the scope of social media research, highlight prominent examples in gastroenterology, and review innovative opportunities and unique challenges to using and studying social media for research.
Literature
1.
Chiang AL. Social media and medicine. Nat Rev Gastroenterol Hepatol. 2020;17:256–257.CrossRef
2.
Chiang AL, Vartabedian B, Spiegel B. Harnessing the hashtag: A standard approach to gi dialogue on social media. Am J Gastroenterol. 2016;111:1082–1084.CrossRef
3.
Bilal M, Oxentenko AS. The impact of twitter: Why should you get involved, and tips and tricks to get started. Am J Gastroenterol. 2020;115:1549–1552.CrossRef
4.
Bilal M, Taleban S, Riegler J, Surawicz C, Feld A. The Do’s and Don’ts of social media: A guide for gastroenterologists. Am J Gastroenterol. 2019;114:375–376.CrossRef
5.
Rubin D. Social Media and Academia: Who, What and Why Bother. Presented at: GUILD Conference; February 16-19, 2020; Maui, Hawaii. 
6.
7.
Mikolajczyk AE, Ufere N, Breu AC, Parikh ND, Garcia-Tsao G, Tapper EB. #LiverTwitter: An emerging tool for liver education and research. Hepatol Commun. 2020;4:1229–1233.CrossRef
8.
Szeto W, van der Bent A, Petty CR, Reich J, Farraye F, Fishman LN. Use of social media for health-related tasks by adolescents with inflammatory bowel disease: A step in the pathway of transition. Inflamm Bowel Dis. 2018;24:1114–1122.CrossRef
9.
10.
Reich J, Guo L, Groshek J et al. Social media use and preferences in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:587–591.CrossRef
11.
Mohanty S, Leader AE, Gibeau E, Johnson C. Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination. Vaccine. 2018;36:5955–5961.CrossRef
12.
Zhang J, Brackbill D, Yang S, Centola D. Efficacy and causal mechanism of an online social media intervention to increase physical activity: Results of a randomized controlled trial. Prev Med Rep. 2015;2:651–657.CrossRef
13.
Pechmann C, Delucchi K, Lakon CM, Prochaska JJ. Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention. Tob Control. 2017;26:188–194.CrossRef
14.
Glanz JM, Wagner NM, Narwaney KJ, et al. Web-based social media intervention to increase vaccine acceptance: A randomized controlled trial. Pediatrics. 2017;140(6):e20171117.
15.
Martinez B, Dailey F, Almario CV et al. Patient understanding of the risks and benefits of biologic therapies in inflammatory bowel disease: Insights from a large-scale analysis of social media platforms. Inflamm Bowel Dis. 2017;23:1057–1064.CrossRef
16.
Hiremath G, Kodroff E, Strobel MJ et al. Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care. Clin Res Hepatol Gastroenterol. 2018;42:483–493.CrossRef
17.
Chang JW, Rubenstein JH, Mellinger JL, et al. Motivations, barriers, and outcomes of patient-reported shared decision making in Eosinophilic Esophagitis. Dig Dis Sci. 2020; epub ahead of print.
18.
Lammert C, Comerford M, Love J, Bailey JR. Investigation gone viral: Application of the social mediasphere in research. Gastroenterology. 2015;149:839–843.CrossRef
19.
Keller MS, Mosadeghi S, Cohen ER, Kwan J, Spiegel BMR. Reproductive health and medication concerns for patients with inflammatory bowel disease: Thematic and quantitative analysis using social listening. J Med Internet Res. 2018;20:e206.CrossRef
20.
Merkel PA, Manion M, Gopal-Srivastava R et al. The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis. 2016;11:66.CrossRef
21.
Ciccarella A, Staley AC, Franco AT. Transforming research: engaging patient advocates at all stages of cancer research. Ann Transl Med. 2018;6:167.CrossRef
22.
Long MD, Kappelman MD, Martin CF et al. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis. 2012;18:2099–2106.CrossRef
23.
Chung AE, Sandler RS, Long MD et al. Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn’s and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners). J Am Med Inform Assoc. 2016;23:485–490.CrossRef
24.
Barnes EL, Kappelman MD, Long MD, Evon DM, Martin CF, Sandler RS. A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of quality of life in patients with inflammatory bowel disease. Am J Gastroenterol. 2019;114:640–647.CrossRef
25.
Geisz M, Ha C, Kappelman MD et al. Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel Disease. Inflamm Bowel Dis. 2016;22:1435–1441.CrossRef
26.
Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis. 2014;20:246–250.CrossRef
27.
Cohen AB, Lee D, Long MD et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58:1322–1328.CrossRef
28.
Bewtra M, Reed SD, Johnson FR et al. Variation among patients with Crohn’s Disease in benefit vs risk preferences and remission time equivalents. Clin Gastroenterol Hepatol. 2020;18:e7.
29.
Hiremath G, Krischer JP, Rothenberg ME, and Dellon ES. Validation of self-reported diagnosis of eosinophilic gastrointestinal disorders patients enrolled in the CEGIR contact registry. Clin Res Hepatol Gastroenterol. 2020; epub ahead of print.
30.
Randell RL, Long MD, Cook SF et al. Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners). Inflamm Bowel Dis. 2014;20:541–544.CrossRef
31.
32.
33.
Frohlich DO. The social construction of inflammatory bowel disease using social media technologies. Health Commun. 2016;31:1412–1420.CrossRef
34.
Olteanu A, Castillo C, Diaz F, and Kiciman E. Social Data: Biases, Methodological Pitfalls, and Ethical Boundaries (December 20, 2016). Frontiers in Big Data. 2019;2:13.
35.
36.
Metadata
Title
Challenges and Opportunities in Social Media Research in Gastroenterology
Authors
Joy W. Chang
Evan S. Dellon
Publication date
01-07-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07058-3

Other articles of this Issue 7/2021

Digestive Diseases and Sciences 7/2021 Go to the issue

Original Article

Real-World Use of Colonoscopy in an Older Population: A Nationwide Standard Cohort Study Using a Common Data Model

Original Article

Pancreas Divisum Increases the Risk of Recurrent Acute Pancreatitis in Patients with rs12338 Polymorphism in the Cathepsin B Gene

Original Article

Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea

Stanford Multidisciplinary Seminars

Strongyloides Superinfection After Liver Transplantion

DDS–SIRC Cooperative Conferences

CEing More—Assessing Small Bowel Crohn’s with Capsule Endoscopy (CE)

Original Article

Volume–Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE—A Feasibility Study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits